Trials / Completed
CompletedNCT03988244
HeartLight X3 Endoscopic Ablation System With Excalibur Balloon for Treatment of Symptomatic Persistent AF
Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) With Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Persistent Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- CardioFocus · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to demonstrate the improved ablation and procedure times of the HeartLight X3 compared to the original HeartLight catheter in the treatment of persistent atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HeartLight X3 | Pulmonary vein isolation |
Timeline
- Start date
- 2019-02-26
- Primary completion
- 2019-04-30
- Completion
- 2020-04-03
- First posted
- 2019-06-17
- Last updated
- 2021-07-20
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT03988244. Inclusion in this directory is not an endorsement.